Frontiers in Cardiovascular Health: Progress in Experimental Cardiology, cartea 9
Editat de Naranjan S. Dhalla, Arun Chockalingam, H. Ivan Berkowitz, Pawan K. Singalen Limba Engleză Hardback – 30 sep 2003
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1089.09 lei 43-57 zile | |
Springer Us – 29 oct 2012 | 1089.09 lei 43-57 zile | |
Hardback (1) | 1094.30 lei 43-57 zile | |
Springer Us – 30 sep 2003 | 1094.30 lei 43-57 zile |
Preț: 1094.30 lei
Preț vechi: 1151.89 lei
-5% Nou
Puncte Express: 1641
Preț estimativ în valută:
209.43€ • 217.54$ • 173.96£
209.43€ • 217.54$ • 173.96£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781402074516
ISBN-10: 1402074514
Pagini: 616
Ilustrații: XVII, 595 p.
Dimensiuni: 155 x 235 x 43 mm
Greutate: 0.98 kg
Ediția:2003
Editura: Springer Us
Colecția Springer
Seria Progress in Experimental Cardiology
Locul publicării:New York, NY, United States
ISBN-10: 1402074514
Pagini: 616
Ilustrații: XVII, 595 p.
Dimensiuni: 155 x 235 x 43 mm
Greutate: 0.98 kg
Ediția:2003
Editura: Springer Us
Colecția Springer
Seria Progress in Experimental Cardiology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. Inflammation and Cardiovascular Disease.- 2. The Role of Inflammation in Cardiac Function and Repair.- 3. Cardiac Repair Following Infarction.- 4. Protein and Phospholipids Composition of Human Myocardium in Children with Congenital Heart Disease.- 5. Human Atherosclerosis: New Participants?.- 6. Aging and Dietary Lipids Modulate Ca2+-Dependent Mitochondrial Function in the Post-Ischemic Heart.- 7. The Role of Nuclear Receptors in HDL Formation.- 8. Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates.- 9. Hypercholesterolemia and Cardiovascular Risk in Diabetic Patients.- 10. Altered Substrate Utilization in the Diabetic Heart: Role of Lipoprotein Lipase.- 11. Does Reperfusion Cause Any Injury to the Myocardium?.- 12. Fulminant Myocarditis—From Lethal Disease to Survival.- 13. Homocysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study.- 14. Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT 1 vs. PPARalpha Effects of Etomoxir.- 15. Mutational Profiles and Molecular Etiologies of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy in Asian Populations.- 16. Flavanol-Rich Foods and Cardiovascular Health.- 17. Benefits of Dietary Fiber for Cardiovascular Disease and Diabetes.- 18. Nutrition and the Brain-Heart Connection.- 19. Vitamin D and Atherosclerosis: A Noteworthy Link.- 20. Congestive Heart Failure as Metabolic Disease.- 21. Conditioned Nutritional Requirements: Therapeutic Relevance to Heart Failure.- 22. Stress and Dietary Fat Influence Cell Membranes and Death Due to Ventricular Fibrillation and Heart Failure.- 23. Pharmacotherapeutics of Diabetic Cardiomyopathy.- 24. Atherosclerotic Regression—A Myth or Reality.- 25. Monolayers of Apolipoprotein AII at the Air/WaterInterface.- 26. Changing Partially Hydrogenated Fat for Palmitic Acid in the Diet Increases LDL-Cholesterol and Endogenous Cholesterol Synthesis in Normocholesterolemic Women.- 27. Cytoprotection of Cardiac Myocytes by Polyunsaturated Fatty Acids.- 28. The Effects of Taurine and Astragalus Membranaceus on Ion Currents and Their Expression in Cardiomyocytes After CVB3 Infection.- 29. CoQ10 in the Treatment of Heart and Vascular Disease.- 30. Global Burden of Cardiovascular Disease: Impending Pandemic in Developing Countries and Economies in Transition.- 31. Cardiovascular Risk Factors in Women.- 32. Cardiovascular Disease in Women in the Middle East.- 33. Hypertension and Diabetes Situation in the Eastern Mediterranean Region: With Special Reference to Iran.- 34. Coronary Artery Disease in Developing and Newly Industrialized Countries: A Scientific Statement of the International College of Cardiology.- 35. Social Inequalities, Nutrition and Health.- 36. The Potential Impact of Cardio Vision 2020 and Three Other Risk Factor Scenarios on Population Rates of Coronary Heart and Cardiovascular Disease: A Call to Action.- 37. Benefits of Exercise in Patients with Congestive Heart Failure.- 38. Cardiac Adaptations to Swim Exercise with Administration of a Cysteine Protease Inhibitor.- 39. Reversal of Coronary Atherosclerosis by Yoga Lifestyle Intervention.- 40. Prevention of Heart Failure—A Clinical Reality?.- 41. Diastolic Dysfunction, Redox Stress, Extracellular Matrix Remodeling and Congestive Heart Failure in Diabetes Mellitus.